(ADM) Archer-Daniels-Midland - Overview
Exchange: NYSE •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US0394831020
Stock: Food Ingredients, Animal Feed, Plant Proteins, Oils
Total Rating 48
Risk 85
Buy Signal 0.28
| Risk 5d forecast | |
|---|---|
| Volatility | 28.2% |
| Relative Tail Risk | -8.89% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.26 |
| Alpha | 35.98 |
| Character TTM | |
|---|---|
| Beta | 0.351 |
| Beta Downside | 0.857 |
| Drawdowns 3y | |
|---|---|
| Max DD | 49.22% |
| CAGR/Max DD | -0.02 |
EPS (Earnings per Share)
Revenue
Description: ADM Archer-Daniels-Midland March 04, 2026
Archer-Daniels-Midland Company (ADM) is a global agricultural origination and processing company. It operates in the Agricultural Products & Services sector, which is characterized by high volume commodity trading and processing. ADMs business model involves sourcing, transporting, and processing agricultural raw materials like oilseeds and grains.
The companys operations are divided into three segments: Ag Services and Oilseeds, Carbohydrate Solutions, and Nutrition. The Ag Services and Oilseeds segment focuses on crushing oilseeds and producing vegetable oils and protein meals. The Carbohydrate Solutions segment processes corn and wheat into various products, including animal feed ingredients. The Nutrition segment develops and sells a wide range of human and animal nutrition ingredients and solutions, such as plant-based proteins and flavors. This diversified approach helps mitigate commodity price volatility.
ADM also engages in related activities like structured trade finance, derivatives trading, and carbon capture initiatives. For a deeper dive into ADMs financial health and market position, consider exploring its comprehensive analysis on ValueRay.
Headlines to watch out for
- Global crop yields and commodity prices impact Ag Services revenue
- Biofuel demand influences corn and oilseed processing margins
- Animal nutrition ingredient sales drive Nutrition segment growth
- Supply chain disruptions increase transportation and processing costs
- Regulatory changes in food and feed additives affect product demand
Piotroski VR‑10 (Strict, 0-10) 5.0
| Net Income: 1.08b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 9.82 > 1.0 |
| NWC/Revenue: 10.13% < 20% (prev 9.10%; Δ 1.04% < -1%) |
| CFO/TA 0.16 > 3% & CFO 5.45b > Net Income 1.08b |
| Net Debt (7.39b) to EBITDA (3.87b): 1.91 < 3 |
| Current Ratio: 11.20 > 1.5 & < 3 |
| Outstanding Shares: last quarter (484.0m) vs 12m ago 0.0% < -2% |
| Gross Margin: 5.80% > 18% (prev 0.07%; Δ 573.4% > 0.5%) |
| Asset Turnover: 182.6% > 50% (prev 160.6%; Δ 22.07% > 0%) |
| Interest Coverage Ratio: 3.16 > 6 (EBITDA TTM 3.87b / Interest Expense TTM 580.0m) |
Altman Z'' 7.92
| A: 0.23 (Total Current Assets 8.94b - Total Current Liabilities 798.0m) / Total Assets 34.66b |
| B: 0.63 (Retained Earnings 21.98b / Total Assets 34.66b) |
| C: 0.04 (EBIT TTM 1.83b / Avg Total Assets 43.97b) |
| D: 3.84 (Book Value of Equity 44.72b / Total Liabilities 11.63b) |
| Altman-Z'' Score: 7.92 = AAA |
Beneish M -3.03
| DSRI: 0.54 (Receivables 3.02b/5.95b, Revenue 80.29b/85.53b) |
| GMI: 1.16 (GM 5.80% / 6.76%) |
| AQI: 1.67 (AQ_t 0.42 / AQ_t-1 0.25) |
| SGI: 0.94 (Revenue 80.29b / 85.53b) |
| TATA: -0.13 (NI 1.08b - CFO 5.45b) / TA 34.66b) |
| Beneish M-Score: -3.03 (Cap -4..+1) = AA |
What is the price of ADM shares?
As of March 11, 2026, the stock is trading at USD 69.39 with a total of 5,132,297 shares traded.
Over the past week, the price has changed by +2.06%, over one month by +1.88%, over three months by +20.10% and over the past year by +41.94%.
Over the past week, the price has changed by +2.06%, over one month by +1.88%, over three months by +20.10% and over the past year by +41.94%.
Is ADM a buy, sell or hold?
Archer-Daniels-Midland has received a consensus analysts rating of 3.00.
Therefor, it is recommend to hold ADM.
- StrongBuy: 1
- Buy: 0
- Hold: 9
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the ADM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 60.7 | -12.5% |
| Analysts Target Price | 60.7 | -12.5% |
ADM Fundamental Data Overview March 11, 2026
P/E Trailing = 30.4574
P/E Forward = 16.4474
P/S = 0.4072
P/B = 1.4275
P/EG = 14.8491
Revenue TTM = 80.29b USD
EBIT TTM = 1.83b USD
EBITDA TTM = 3.87b USD
Long Term Debt = 7.61b USD (from longTermDebt, last quarter)
Short Term Debt = 798.0m USD (from shortTermDebt, last quarter)
Debt = 8.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.39b USD (from netDebt column, last quarter)
Enterprise Value = 40.08b USD (32.68b + Debt 8.41b - CCE 1.01b)
Interest Coverage Ratio = 3.16 (Ebit TTM 1.83b / Interest Expense TTM 580.0m)
EV/FCF = 9.53x (Enterprise Value 40.08b / FCF TTM 4.20b)
FCF Yield = 10.49% (FCF TTM 4.20b / Enterprise Value 40.08b)
FCF Margin = 5.24% (FCF TTM 4.20b / Revenue TTM 80.29b)
Net Margin = 1.34% (Net Income TTM 1.08b / Revenue TTM 80.29b)
Gross Margin = 5.80% ((Revenue TTM 80.29b - Cost of Revenue TTM 75.63b) / Revenue TTM)
Gross Margin QoQ = 6.54% (prev 6.23%)
Tobins Q-Ratio = 1.16 (Enterprise Value 40.08b / Total Assets 34.66b)
Interest Expense / Debt = 1.69% (Interest Expense 142.0m / Debt 8.41b)
Taxrate = 4.62% (22.0m / 476.0m)
NOPAT = 1.75b (EBIT 1.83b * (1 - 4.62%))
Current Ratio = 11.20 (Total Current Assets 8.94b / Total Current Liabilities 798.0m)
Debt / Equity = 0.37 (Debt 8.41b / totalStockholderEquity, last quarter 22.73b)
Debt / EBITDA = 1.91 (Net Debt 7.39b / EBITDA 3.87b)
Debt / FCF = 1.76 (Net Debt 7.39b / FCF TTM 4.20b)
Total Stockholder Equity = 22.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 1.08b / Total Assets 34.66b)
RoE = 4.80% (Net Income TTM 1.08b / Total Stockholder Equity 22.44b)
RoCE = 6.11% (EBIT 1.83b / Capital Employed (Equity 22.44b + L.T.Debt 7.61b))
RoIC = 5.54% (NOPAT 1.75b / Invested Capital 31.58b)
WACC = 6.06% (E(32.68b)/V(41.09b) * Re(7.21%) + D(8.41b)/V(41.09b) * Rd(1.69%) * (1-Tc(0.05)))
Discount Rate = 7.21% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -4.53%
[DCF] Terminal Value 87.85% ; FCFF base≈3.01b ; Y1≈3.72b ; Y5≈6.33b
[DCF] Fair Price = 347.6 (EV 174.64b - Net Debt 7.39b = Equity 167.24b / Shares 481.2m; r=6.06% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -92.41 | EPS CAGR: -18.80% | SUE: -0.15 | # QB: 0
Revenue Correlation: -88.20 | Revenue CAGR: -6.26% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.95 | Chg7d=-0.017 | Chg30d=-0.085 | Revisions Net=-3 | Analysts=9
EPS current Year (2026-12-31): EPS=4.01 | Chg7d=+0.000 | Chg30d=-0.053 | Revisions Net=-8 | Growth EPS=+16.8% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=4.66 | Chg7d=+0.000 | Chg30d=+0.007 | Revisions Net=-2 | Growth EPS=+16.4% | Growth Revenue=+2.4%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 7.9% - Earnings Yield 3.3%)
[Growth] Growth Spread = -3.9% (Analyst 0.8% - Implied 4.7%)
P/E Forward = 16.4474
P/S = 0.4072
P/B = 1.4275
P/EG = 14.8491
Revenue TTM = 80.29b USD
EBIT TTM = 1.83b USD
EBITDA TTM = 3.87b USD
Long Term Debt = 7.61b USD (from longTermDebt, last quarter)
Short Term Debt = 798.0m USD (from shortTermDebt, last quarter)
Debt = 8.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 7.39b USD (from netDebt column, last quarter)
Enterprise Value = 40.08b USD (32.68b + Debt 8.41b - CCE 1.01b)
Interest Coverage Ratio = 3.16 (Ebit TTM 1.83b / Interest Expense TTM 580.0m)
EV/FCF = 9.53x (Enterprise Value 40.08b / FCF TTM 4.20b)
FCF Yield = 10.49% (FCF TTM 4.20b / Enterprise Value 40.08b)
FCF Margin = 5.24% (FCF TTM 4.20b / Revenue TTM 80.29b)
Net Margin = 1.34% (Net Income TTM 1.08b / Revenue TTM 80.29b)
Gross Margin = 5.80% ((Revenue TTM 80.29b - Cost of Revenue TTM 75.63b) / Revenue TTM)
Gross Margin QoQ = 6.54% (prev 6.23%)
Tobins Q-Ratio = 1.16 (Enterprise Value 40.08b / Total Assets 34.66b)
Interest Expense / Debt = 1.69% (Interest Expense 142.0m / Debt 8.41b)
Taxrate = 4.62% (22.0m / 476.0m)
NOPAT = 1.75b (EBIT 1.83b * (1 - 4.62%))
Current Ratio = 11.20 (Total Current Assets 8.94b / Total Current Liabilities 798.0m)
Debt / Equity = 0.37 (Debt 8.41b / totalStockholderEquity, last quarter 22.73b)
Debt / EBITDA = 1.91 (Net Debt 7.39b / EBITDA 3.87b)
Debt / FCF = 1.76 (Net Debt 7.39b / FCF TTM 4.20b)
Total Stockholder Equity = 22.44b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 1.08b / Total Assets 34.66b)
RoE = 4.80% (Net Income TTM 1.08b / Total Stockholder Equity 22.44b)
RoCE = 6.11% (EBIT 1.83b / Capital Employed (Equity 22.44b + L.T.Debt 7.61b))
RoIC = 5.54% (NOPAT 1.75b / Invested Capital 31.58b)
WACC = 6.06% (E(32.68b)/V(41.09b) * Re(7.21%) + D(8.41b)/V(41.09b) * Rd(1.69%) * (1-Tc(0.05)))
Discount Rate = 7.21% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -81.65 | Cagr: -4.53%
[DCF] Terminal Value 87.85% ; FCFF base≈3.01b ; Y1≈3.72b ; Y5≈6.33b
[DCF] Fair Price = 347.6 (EV 174.64b - Net Debt 7.39b = Equity 167.24b / Shares 481.2m; r=6.06% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -92.41 | EPS CAGR: -18.80% | SUE: -0.15 | # QB: 0
Revenue Correlation: -88.20 | Revenue CAGR: -6.26% | SUE: -4.0 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.95 | Chg7d=-0.017 | Chg30d=-0.085 | Revisions Net=-3 | Analysts=9
EPS current Year (2026-12-31): EPS=4.01 | Chg7d=+0.000 | Chg30d=-0.053 | Revisions Net=-8 | Growth EPS=+16.8% | Growth Revenue=+3.5%
EPS next Year (2027-12-31): EPS=4.66 | Chg7d=+0.000 | Chg30d=+0.007 | Revisions Net=-2 | Growth EPS=+16.4% | Growth Revenue=+2.4%
[Analyst] Revisions Ratio: -0.60 (1 Up / 4 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 4.7% (Discount Rate 7.9% - Earnings Yield 3.3%)
[Growth] Growth Spread = -3.9% (Analyst 0.8% - Implied 4.7%)